224 related articles for article (PubMed ID: 25212199)
1. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control.
Churchyard GJ; Chaisson RE; Maartens G; Getahun H
S Afr Med J; 2014 Apr; 104(5):339-43. PubMed ID: 25212199
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.
Ayele HT; Mourik MS; Debray TP; Bonten MJ
PLoS One; 2015; 10(11):e0142290. PubMed ID: 26551023
[TBL] [Abstract][Full Text] [Related]
4. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
5. Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.
Sumner T; Houben RM; Rangaka MX; Maartens G; Boulle A; Wilkinson RJ; White RG
AIDS; 2016 May; 30(8):1279-86. PubMed ID: 26950316
[TBL] [Abstract][Full Text] [Related]
6. Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children.
Luabeya KK; Tameris MD; Geldenhuys HD; Mulenga H; Van Schalkwyk A; Hughes EJ; Toefey A; Scriba TJ; Hussey G; Mahomed H; McShane H; Landry B; Hanekom WA; Hatherill M
Pediatr Infect Dis J; 2015 Nov; 34(11):1218-22. PubMed ID: 26252568
[TBL] [Abstract][Full Text] [Related]
7. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
[TBL] [Abstract][Full Text] [Related]
8. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
9. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
11. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.
Kendall EA; Azman AS; Maartens G; Boulle A; Wilkinson RJ; Dowdy DW; Rangaka MX
AIDS; 2019 Mar; 33(3):525-536. PubMed ID: 30325773
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
van Halsema CL; Fielding KL; Chihota VN; Russell EC; Lewis JJ; Churchyard GJ; Grant AD
AIDS; 2010 Apr; 24(7):1051-5. PubMed ID: 20299958
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
14. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.
Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Mosimaneotsile B; Motsamai OI; Shang N; Rose CE; Shepherd J
AIDS; 2015 Jan; 29(3):351-9. PubMed ID: 25686683
[TBL] [Abstract][Full Text] [Related]
17. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
18. Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.
Mills HL; Cohen T; Colijn C
J R Soc Interface; 2011 Oct; 8(63):1510-20. PubMed ID: 21508012
[TBL] [Abstract][Full Text] [Related]
19. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
Ayele HT; van Mourik MS; Bonten MJ
BMC Infect Dis; 2015 Aug; 15():334. PubMed ID: 26269094
[TBL] [Abstract][Full Text] [Related]
20. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
Charalambous S; Grant AD; Innes C; Hoffmann CJ; Dowdeswell R; Pienaar J; Fielding KL; Churchyard GJ
AIDS; 2010 Nov; 24 Suppl 5(0 5):S5-13. PubMed ID: 21079429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
